Simbiosys

SimBioSys secures $15 million in Series A funding for computational oncology software

Merck logo

EMA begins rolling review of Merck’s and Ridgeback’s COVID-19 pill molnupiravir

Clinical worker

Simplifying safety reporting as part of clinical trial investigator retention 

Moderna

Moderna releases positive interim Phase 2/3 COVID-19 vaccine data for children 6 to 11

Pfizer-BioNTech

Pfizer-BioNTech COVID-19 vaccine was 91% effective in 5- to 11-year-olds in Phase 3 study

Athira Pharma

Athira Pharma CEO steps down in the wake of research misconduct allegations

CDC COVID-19

CDC panel unanimously backs J&J and Moderna vaccine boosters 

TORX

Torx Software bolsters web-based platform for small-molecule drug discovery

CDC COVID-19

ACIP votes unanimously backs GSK’s shingles vaccine Shingrix for immunocompromised adults 19 and older